A cancer specialist and a medical ethicist offer their view of a “patient-centered” approach to new drug development and approval, beginning with cancer drugs.

European researchers have unraveled the genetics of an incurable subtype of acute lymphoblastic leukemia, the most common malignancy among children in industrialized nations.

The first patient treated with a drug that targets TRK fusion proteins had significant regression of advanced soft-tissue sarcoma.

An oncologist’s real-life patient vignette adds support to a recent studyshowing that “palliative chemotherapy” often fails to palliate.

A study of clinical trials involving approved drugs — many of them cancer drugs — showed that almost two thirds of the consent forms made no mention of potential adverse effects included in the drugs’ FDA-mandated “black-box” warnings.

The colonoscopy of the future could be kinder and gentler if an investigational adjustable-focus endoscope pans out.

An Illinois-based company faces legal action that involves the U.S. Equal Opportunity Employment Commission over the termination of an employee who has cancer.

U.S. and Russian scientists have teamed up to examine a potential biologic basis for electromagnetic energy — the kind produced by cell phones and other wireless devices — to cause cancer.

Seven years into a diagnosis of colorectal cancer, a man and his family reflect on the financial hardship and stress caused by medical bills, despite having health insurance.